Litigation Details for Plexxikon Inc. v. Novartis Pharmaceuticals Corporation (N.D. Cal. 2017)
✉ Email this page to a colleague
Plexxikon Inc. v. Novartis Pharmaceuticals Corporation (N.D. Cal. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-08-03 |
| Court | District Court, N.D. California | Date Terminated | 2021-09-17 |
| Cause | 35:271 Patent Infringement | Assigned To | Haywood Stirling Gilliam Jr. |
| Jury Demand | Plaintiff | Referred To | Alex G. Tse |
| Parties | GLAXOSMITHKLINE PLC | ||
| Patents | 7,994,185 | ||
| Attorneys | Laura Elizabeth Miller | ||
| Firms | McDermott Will and Emery LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Plexxikon Inc. v. Novartis Pharmaceuticals Corporation
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Plexxikon Inc. v. Novartis Pharmaceuticals Corporation (N.D. Cal. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-08-03 | 1 | reproduced from US 7,994,185 B2, column 3, lines 30-40), next to formula Ia of the ’640 patent. GSK’s 28 infringing…et seq. for infringement of U.S. Patent No. 9,469,640 (“the ’640 patent”) through Novartis’s 6 importation…matured into the ’640 patent at issue in this case. 21 17. The ’640 patent covers a class of …NOVARTIS’S INFRINGEMENT OF THE ’640 PATENT 4 19. The ’640 patent was duly and legally issued on…the United Patent and 5 Trademark Office (“PTO”). A true and correct copy of the ’640 patent is attached | External link to document | |
| 2017-11-02 | 40 | reproduced from US 7,994,185 B2, column 3, lines 30-40), next to formula Ia of the ’640 patent. GSK’s 2 …et seq. for infringement of U.S. Patent No. 9,469,640 (“the ’640 patent”) through Novartis’s 6 importation…the ’640 patent at issue in this case. 21 17. A second application, U.S. patent application…NOVARTIS’S INFRINGEMENT OF THE ’640 PATENT 9 20. The ’640 patent was duly and legally issued on…the United Patent and 10 Trademark Office (“PTO”). A true and correct copy of the ’640 patent is attached | External link to document | |
| 2017-12-19 | 55 | reproduced from US 7,994,185 B2, column 3, lines 30-40), next to formula Ia of the ’640 16 patent and the ’539….S. Patent No. 9,469,640 (“the ‘640 patent”) and U.S. Patent No. 6 9,844,539 (“the ‘539 patent”) through…those that matured into the ’640 20 patent and the ‘539 patent which are at issue in this case. 21 …21 17. The ’640 patent and the ‘539 patent cover a class of selective BRAF kinase inhibitors…NOVARTIS’S INFRINGEMENT OF THE ’640 PATENT 4 19. The ’640 patent was duly and legally issued on | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
